Company / Operating Cash Flow
ANAPTYSBIO, INC Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$19.7M
FY2025
5-year range
-$135.3M / $19.7M
FY2021-FY2025
Trend
+114.6%
vs FY2024
Sector context
#72 of 216
Health Care
What the data says
At $20M, ANAPTYSBIO, INC's operating cash flow ranks #72 of 216 in the Health Care sector. Operating Cash Flow returned to growth in FY2025 after 2 years of decline, reaching $20M.
Based on SEC 10-K filings.
$20M in FY2025.
Improved from -$121M to $20M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#72 of 216 in Health CareTop 33% of 216This company $19.7M Sector average $658.7M
▼
-97.0% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow increased 114.6% year-over-year.
- Ranks #72 out of 216 companies in the Health Care sector.
- Lowest operating cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.7M | +114.6% |
| FY2024 | -$135.3M | -12.0% |
| FY2023 | -$120.8M | -753.3% |
| FY2022 | -$14.2M | +79.6% |
| FY2021 | -$69.5M | -43.3% |
| FY2020 | -$48.5M | -149.5% |
| FY2019 | -$19.4M | +59.9% |
| FY2018 | -$48.5M | -400.4% |
| FY2017 | -$9.7M | -7.4% |
| FY2016 | -$9.0M | +6.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026